Perspective Therapeutics CATX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's accrued expenses?
- Perspective Therapeutics (CATX) reported accrued expenses of $3.88M in Q1 2026.
- How has Perspective Therapeutics's accrued expenses changed year-over-year?
- Perspective Therapeutics's accrued expenses increased by 33.1% year-over-year, from $2.91M to $3.88M.
- What is the long-term trend for Perspective Therapeutics's accrued expenses?
- Over 5 years (2020 to 2025), Perspective Therapeutics's accrued expenses has grown at a 136.6% compound annual growth rate (CAGR), from $101K to $7.49M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.